Kursprognose für Coherus Oncology Inc (CHRS)

$0.749

-0.089 (-11.91%)Zum Schluss

Kursprognosen

1-Day Price Prediction

+0.03%

1-Week Prediction

+1.54%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.

Loading chart…

CHRS-Prognose durch Analyse ähnlicher Charts

Alphio's CHRS stock price prediction model matches the current Coherus Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.75 (+0.03%). The 1-week path is $0.76 (+1.54%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Soll ich Coherus Oncology Inc-Aktien kaufen?

Coherus BioSciences Inc (CHRS) appears to be a good buy at the current price of $0.7494, especially considering its RSI of 23.693, indicating it is oversold. The company has a strong gross margin of 70.35% in Q2 2026, which suggests efficient cost management and potential for profitability as revenues grow. However, the main risk is the forward P/E of 41.1523, indicating high expectations for future earnings that may not materialize, especially given the recent net income losses.

CHRS schloss am Thursday bei $0.75, nachdem der Kurs -11.91% fallen

Coherus Oncology Inc (CHRS) last closed at $0.7489, losing -11.91%. These facts feed the 1-day and 1-week CHRS price prediction above.

Analystenkonsens

Coherus Oncology Inc (CHRS): 8 Kaufen, 0 Halten, 0 Verkaufen. Ausblick: Strong Buy.

Sell / Buy

Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.

Strong buy

Sell

Buy

Prognose-Treiber

Die Prognose-Treiber von Coherus Oncology Inc (CHRS) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

Saisonalitätsanalyse für CHRS

Historically the probability of a positive November return for CHRS is 9.30%. January offers the highest probability of a positive month at 44.26%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…